Latest News for Geron Stock (NASDAQ:GERN)

Wednesday, November 29, 2023

Director at Geron Acquires Company Stock Options Worth 200,000 Shares
Benzinga Insights - 4 days ago

Thursday, November 02, 2023

Geron IMerge Phase 3 Presentations At Upcoming ASH Annual Meeting Reinforce Significant Durability And Breadth Of Effect Of Imetelstat In Lower Risk MDS
Benzinga Newsdesk - Nov 2, 2023, 9:17AM
Geron's As Of September 30, 2023, Had $381.9M In Cash, Cash Equivalents, And Marketable Securities Expected To Be Sufficient To Fund Its Projected Operating Requirements Through The End Of Q3 2025
Benzinga Newsdesk - Nov 2, 2023, 8:03AM
Geron Q3 EPS $(0.08) Beats $(0.10) Estimate, Sales $164.00K Beat $59.00K Estimate
Benzinga Newsdesk - Nov 2, 2023, 8:01AM
Earnings Scheduled For November 2, 2023
Benzinga Insights - Nov 2, 2023, 4:56AM

Wednesday, November 01, 2023

Geron Earnings Preview
Benzinga Insights - Nov 1, 2023, 1:02PM

Wednesday, October 04, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Oct 4, 2023, 12:01PM

Tuesday, October 03, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Oct 3, 2023, 2:37PM

Friday, September 29, 2023

Geron Announced That The European Medicines Agency Has Validated Imetelstat Marketing Authorization Application For Transfusion-dependent Anemia In Patients With Lower-risk Myelodysplastic Syndromes. The Review Is Expected To Be Approximately 14 Months
Benzinga Newsdesk - Sep 29, 2023, 8:11AM

Thursday, September 28, 2023

EVP at Geron Acquires Company Stock Options Worth 1,350,000 Shares
Benzinga Insights - Sep 28, 2023, 11:00AM

Friday, September 22, 2023

Geron Chairman Awarded $1.07M Worth of Stock Options
Benzinga Insights - Sep 22, 2023, 11:00AM
EVP at Geron Acquires Company Stock Options Worth 200,000 Shares
Benzinga Insights - Sep 22, 2023, 11:00AM
EVP at Geron Acquires Company Stock Options Worth 221,544 Shares
Benzinga Insights - Sep 22, 2023, 11:00AM
EVP at Geron Acquires Company Stock Options Worth 250,000 Shares
Benzinga Insights - Sep 22, 2023, 11:00AM

Tuesday, September 12, 2023

Recent Pullback Buying Opportunity For Blood Cancer Firm Geron: Goldman Sachs
Vandana Singh - Sep 12, 2023, 2:43PM
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
Benzinga Insights - Sep 12, 2023, 11:00AM
Geron shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and announced a $4 price target.
Benzinga Newsdesk - Sep 12, 2023, 8:49AM
Geron Corp Names Michelle J. Robertson of Editas Medicine, Inc as CFO Effective September 25 as Olivia K. Bloom Retires From the Company
Benzinga Newsdesk - Sep 12, 2023, 6:04AM
Goldman Sachs Upgrades Geron to Buy, Announces $4 Price Target
Benzinga Newsdesk - Sep 12, 2023, 5:28AM

Monday, September 11, 2023

Geron Announces Appointment Of Michelle Robertson As Executive Vice President, Chief Financial Officer And Treasurer, And Retirement Of CFO Olivia Bloom
Bill Haddad - Sep 11, 2023, 4:31PM

Thursday, September 07, 2023

Geron Announces Data Presentations From IMerge Phase 3 Evaluating Imetelstat In Lower Risk MDS At Society Of Hematologic Oncology Annual Meeting
Happy Mohamed - Sep 7, 2023, 8:03AM

Tuesday, August 29, 2023

Wedbush Reiterates Outperform on Geron, Maintains $6 Price Target
Benzinga Newsdesk - Aug 29, 2023, 7:57AM

Tuesday, August 22, 2023

Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Aug 22, 2023, 1:49PM
FDA Has Assigned A Standard Review And A Prescription Drug User Fee Act Action Date Of June 16, 2024 For Geron's New Drug Application For Imetelstat For Transfusion-dependent Anemia In Patients With Lower-risk Myelodysplastic Syndromes
Benzinga Newsdesk - Aug 22, 2023, 8:03AM

Monday, August 21, 2023

Geron Announces FDA Acceptance Of New Drug Application For Imetelstat For The Treatment Of Lower Risk MDS
Benzinga Newsdesk - Aug 21, 2023, 8:02AM

Friday, August 04, 2023

Geron EVP Awarded $4.04M Worth of Stock Options
Benzinga Insights - Aug 4, 2023, 11:01AM
Needham Reiterates Buy on Geron, Maintains $4 Price Target
Benzinga Newsdesk - Aug 4, 2023, 6:30AM

Thursday, August 03, 2023

Geron Q2 EPS $(0.09) Misses $(0.08) Estimate, Sales $29.00K Miss $70.00K Estimate
Benzinga Newsdesk - Aug 3, 2023, 4:54PM
Earnings Scheduled For August 3, 2023
Benzinga Insights - Aug 3, 2023, 6:59AM

Tuesday, June 20, 2023

What's Going On With Geron Stock Today
Vandana Singh - Jun 20, 2023, 11:32AM
Geron shares are trading higher after the company submitted FDA application for imetelstat for transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes.
Benzinga Newsdesk - Jun 20, 2023, 10:58AM
Geron Announces Submission Of New Drug Application To FDA For First-in-Class Telomerase Inhibitor Imetelstat
Benzinga Newsdesk - Jun 20, 2023, 9:17AM

Thursday, June 15, 2023

Needham Reiterates Buy on Geron, Maintains $4 Price Target
Benzinga Newsdesk - Jun 15, 2023, 4:09AM

Tuesday, June 13, 2023

Geron Announces First Patient Dosed In Investigator-Led Phase 2 IMpress Trial Evaluating Imetelstat In Patients With Relapsed/Refractory AML Or Higher Risk MDS
Benzinga Newsdesk - Jun 13, 2023, 9:02AM

Monday, June 05, 2023

Needham Reiterates Buy on Geron, Maintains $4 Price Target
Benzinga Newsdesk - Jun 5, 2023, 5:24AM

Friday, June 02, 2023

Geron Announces ASCO Presentation Reporting Durable Continuous Transfusion Independence With Imetelstat In IMerge Phase 3 Lower Risk MDS Patients
Happy Mohamed - Jun 2, 2023, 3:31PM

Friday, May 26, 2023

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin - May 26, 2023, 12:48PM
Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday
Lisa Levin - May 26, 2023, 10:46AM

Thursday, May 25, 2023

Geron Highlights Oral Presentation At ASCO 2023 Meeting; To Show 'Meaningful Continuous Transfusion Independence Observed in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3'
Benzinga Newsdesk - May 25, 2023, 5:07PM

Monday, May 22, 2023

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - May 22, 2023, 1:35PM

Friday, May 12, 2023

Wedbush Reiterates Outperform on Geron, Maintains $6 Price Target
Benzinga Newsdesk - May 12, 2023, 9:47AM

Thursday, May 11, 2023

Earnings Scheduled For May 11, 2023
Benzinga Insights - May 11, 2023, 9:58AM
Recap: Geron Q1 Earnings
Benzinga Insights - May 11, 2023, 8:09AM
Geron Q1 EPS $(0.07) Beats $(0.10) Estimate, Sales $21.00K Miss $80.00K Estimate
Benzinga Newsdesk - May 11, 2023, 8:01AM

Wednesday, May 10, 2023

A Preview Of Geron's Earnings
Benzinga Insights - May 10, 2023, 10:03AM

Wednesday, April 26, 2023

Geron Announces Upcoming Oral Presentation At 2023 American Society Of Clinical Oncology Annual Meeting Of Imetelstat Data From IMerge Phase 3 Lower Risk MDS Trial
Happy Mohamed - Apr 26, 2023, 10:06AM

Friday, April 21, 2023

Needham Reiterates Buy on Geron, Maintains $4 Price Target
Benzinga Newsdesk - Apr 21, 2023, 6:58AM

Tuesday, March 28, 2023

Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
Benzinga Insights - Mar 28, 2023, 11:00AM
Goldman Sachs Initiates Coverage On Geron with Neutral Rating, Announces Price Target of $3
Benzinga Newsdesk - Mar 28, 2023, 4:44AM

Monday, March 20, 2023

B. Riley Securities Reiterates Buy on Geron, Maintains $5 Price Target
Benzinga Newsdesk - Mar 20, 2023, 9:28AM

Open1.920	Close1.990
Vol / Avg.4.092M / 5.493M	Mkt Cap1.086B
Day Range1.870 - 1.995	52 Wk Range1.680 - 3.840

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Geron Stock (NASDAQ:GERN)

Wednesday, November 29, 2023

Thursday, November 02, 2023

Wednesday, November 01, 2023

Wednesday, October 04, 2023

Tuesday, October 03, 2023

Friday, September 29, 2023

Thursday, September 28, 2023

Friday, September 22, 2023

Tuesday, September 12, 2023

Monday, September 11, 2023

Thursday, September 07, 2023

Tuesday, August 29, 2023

Tuesday, August 22, 2023

Monday, August 21, 2023

Friday, August 04, 2023

Thursday, August 03, 2023

Tuesday, June 20, 2023

Thursday, June 15, 2023

Tuesday, June 13, 2023

Monday, June 05, 2023

Friday, June 02, 2023

Friday, May 26, 2023

Thursday, May 25, 2023

Monday, May 22, 2023

Friday, May 12, 2023

Thursday, May 11, 2023

Wednesday, May 10, 2023

Wednesday, April 26, 2023

Friday, April 21, 2023

Tuesday, March 28, 2023

Monday, March 20, 2023